Dr. John Cush RheumNow
4 years 3 months ago
Amitriptyline and FDA Treatments for Fibromyalgia #MedEd
https://t.co/zA4rycnHg4 https://t.co/TxD1jp6XGf
Dr. John Cush RheumNow
4 years 3 months ago
Watch: Lupus Nephritis: The Blind Men and the Kidney with Dr. Joan Merrill
Joan Merrill discusses treatment of lupus nephritis. This was previously recorded at RheumNow Live 2022.
https://t.co/9GRw5VGTKr https://t.co/PS6aEk1fsx
Dr. John Cush RheumNow
4 years 3 months ago
Visit @RheumNow podcast channel & hear experts from the #SLEEducatorsNetwork review a new framework for defining disease modification in SLE and why there’s a need to consider therapies that modify the immunologic mechanisms of SLE. Sponsored by GSK USMA
https://t.co/gsrYmu5ufO https://t.co/Fmt21u3wUN
Dr. John Cush RheumNow
4 years 3 months ago
Dr. Jack Cush reviews the news, regulatory updates and journal reports from the past week on https://t.co/V10S4oVFsv. This week gout worries, mortality risks, measuring anti-drug antibodies and a better way in lupus?
https://t.co/iaMQZtzdLm https://t.co/Zu9VwKoCAc
Dr. John Cush RheumNow
4 years 3 months ago
Looking forward to reading/watching the coverage of #EULAR2022 by our outstanding faculty, including Drs., Rachel Tate @uptoTate, Kathryn Dao @KDAO2011,
Robert Chao @doctorRBC , Janet Pope @Janetbirdope and Antoni Chan @synovialjoints . https://t.co/oBQCxzdzfF
Dr. John Cush RheumNow
4 years 3 months ago
Join experts from the #SLEEducatorsNetwork to learn more about our current understanding of SLE pathophysiology & why, given its progressive nature, there’s a need to try to change the course of this complex disease. Sponsored by GSK USMA @jeevsmd https://t.co/WkL1lU2JRJ https://t.co/g8iv6WUG5k
Dr. John Cush RheumNow
4 years 3 months ago
Watch: Novel Treatment of SLE
Dr. Sonali Narain discusses new insights on existing treatments and newly approved therapy and soon to be approved therapies for SLE. #MedEd
https://t.co/7Op3R8IzV1
#MedEdTwitter https://t.co/qBMTbOBmyM
Dr. John Cush RheumNow
4 years 3 months ago
Long COVID Manifestations
The acute consequences of a SARS-CoV-2 infection may be bothersome or devastating, but the long-term consequences may lead to so-called "long COVID" syndrome. Long COVID appears to affect up to 20% of those who survive COVID-19.
https://t.co/BFgazzEQWl https://t.co/0HyWZ3HcLG
This week's Tuesday Night Rheumatology, hosted by Dr. Jack Cush, featured highlights from the 2022 RheumNow Live Rheumatoid Arthritis - Best Management Pod, followed by a lively audience Q & A. Lectures featured:
- Drug Cycling Vs Switching in RA - Janet Pope, MD, MPH, FRCPC
- Multimorbidity in RA - Elena Myasoedova, MD, PhD
- Preventing Rheumatoid Arthritis - Karen Costenbader, MD
Dr. John Cush RheumNow
4 years 3 months ago
Novel patient self-drawn capillary (CAP) tube blood testing for CRP/RF/CCP - YES, Pt does this at home! 49/50 seropos.RA pts successfully collected samples; , correlations w/ venous blood=excellent: CRP (0.992), CCP (0.984), RF (0.994) https://t.co/zLiwEpiyi9
Conclusions
Dr. John Cush RheumNow
4 years 3 months ago
Watch: Treatment Choices in Refractory RA
Dr. Cush presents Treatment Choices in Refractory RA, during the RheumNow Live 2022 meeting held in March 2022. #MedEd
https://t.co/5wjLyVAS7o https://t.co/dnh8Y5Of4G
Dr. John Cush RheumNow
4 years 3 months ago
UK experience with 7 cases of monkeypox. Common sxs=fever, rash, HA, lymphadenopathy, LFTs. Complications =pneumonitis, encephalitis, keratitis, bacterial infx. Often skin lesions, abscesses https://t.co/OW3VMtGTGD https://t.co/yTKODreXYg
